Trending

24/7 MN (NASDAQ: REVB) REVELATION BIOSCIENCES shares are soaring at the open on a continuation of the news of Phase 2 efficacy. Shares are now up 92% this morning with 30,306 trades & 6.4 million in volume.

Revelation Biosciences Inc. Announces Topline Data for Phase 1b CLEAR Clinical Study of REVTx-99b for the Treatment of Allergic Rhinitis

https://www.globenewswire.com/news-release/2022/07/22/2484694/0/en/Revelation-Biosciences-Inc-Announces-Topline-Data-for-Phase-1b-CLEAR-Clinical-Study-of-REVTx-99b-for-the-Treatment-of-Allergic-Rhinitis.html

RelatedNews

Signup today for free and be the first to get notified of breaking news.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

SIGN UP FOR OUR NEWSLETTER

Sign up for Breaking Alerts, our newsletter putting timely and updated stock and crypto markets news into your hands.

Add New Playlist